Remove solutions participant-identification
article thumbnail

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

There are 5 guiding principles for defining quality that should inform DCTs: Have we enrolled the right participants according to the protocol with adequate consent? Did participants receive the assigned treatment and did they stay on the treatment? What we often do not think about is verifying the identity of the participant.

article thumbnail

Transforming Your Informed Consent Process

Cloudbyz

Here are some of the hot features that most organizations are currently looking for in their eConsent solution: User Friendly. A user friendly eConsent form provides a seamless experience for the participants. Configuring lag time allows participants to take their time in understanding the study. Authentication. Query handling.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The next phase of decentralisation in clinical trials

Pharmaceutical Technology

The result is an improved experience for patients, whose participation no longer rests on long journeys to and from sites. Decentralisation has the potential to solve a lot of these challenges, particularly around participation rates but also importantly around diversity.”

article thumbnail

Pharmacovigilance in Clinical Trials: Safeguarding Participant Safety and Ensuring Data Integrity

Cloudbyz

However, ensuring participant safety is paramount throughout the trial process. Pharmacovigilance plays a critical role in monitoring adverse events, collecting safety data, and reporting requirements to protect participants.

article thumbnail

IN FOCUS: Walgreens

Pharmaceutical Technology

Using a tech-enabled approach to patient identification and creating a large registry of clinical trial participants, Walgreens will reduce the time it takes to match eligible patients to clinical trials and provide another offering for patients with complex or chronic conditions in their care journey.

Pharmacy 130
article thumbnail

10 Reasons Why Your CTMS Needs to Be on the Salesforce Platform

Cloudbyz

Limited visibility and oversight: Lack of real-time monitoring and reporting functionalities can hinder proactive issue identification and jeopardize patient safety and study timelines. Where does Salesforce comes in this picture : Salesforce, a leader in the CRM world, surprisingly emerges as a formidable solution for clinical trials.

article thumbnail

Top Site Challenges of 2023 – Data and Insights on Site Burden and Trial Efficiency

ACRP blog

Ten Ways Clinical Research Sites Can Address Their Key Challenges: Focus on the participant experience throughout the recruitment, enrollment, and retention process. Leverage data and technology to optimize participant recruitment, enrollment, and retention.

Trials 52